Company profile CGEN

Compugen Ltd
Description of the company is not available.
Quarter analysis & expected interestLast update: February 08 2024 18:32:51.

After 39 days of this quarter the interest is at 90.0. Based on that we can calculate that during remaining 52 days it will total up to 210.0.
Compugen expected interest is significantly higher compared to same quarter last year (+94.4%) but similar to previous quarter.

YearQ1Q2Q3Q4
2019125
140
12.0% QoQ
71
-49.3% QoQ
230
223.9% QoQ
2020 260
108.0% YoY 13.0% QoQ
553
295.0% YoY 112.7% QoQ
291
309.9% YoY -47.4% QoQ
209
-9.1% YoY -28.2% QoQ
2021 212
-18.5% YoY 1.4% QoQ
167
-69.8% YoY -21.2% QoQ
138
-52.6% YoY -17.4% QoQ
178
-14.8% YoY 29.0% QoQ
2022 125
-41.0% YoY -29.8% QoQ
97
-41.9% YoY -22.4% QoQ
152
10.1% YoY 56.7% QoQ
107
-39.9% YoY -29.6% QoQ
2023 108
-13.6% YoY 0.9% QoQ
190
95.9% YoY 75.9% QoQ
130
-14.5% YoY -31.6% QoQ
251
134.6% YoY 93.1% QoQ
2024 90
-16.7% YoY -64.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Compugen search interestLast update: February 08 2024 18:32:50.
Correlation coefficient between keyword and revenue is -0.34
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 18:32:52.

The average 5 years interest of Compugen was 14.65 per week.
The last year interest of Compugen compared to the last 5 years has changed by -7.03%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 10.64%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Compugen immuno-oncology to provide analysis

Correlation between past revenue and Compugen immuno-oncology search interest

There is not enough data for Compugen immuno-oncology to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Compugen immuno-oncology to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Compugen COM701 to provide analysis

Correlation between past revenue and Compugen COM701 search interest

There is not enough data for Compugen COM701 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Compugen COM701 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Compugen COM902 to provide analysis

Correlation between past revenue and Compugen COM902 search interest

There is not enough data for Compugen COM902 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Compugen COM902 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Compugen Bapotulimab to provide analysis

Correlation between past revenue and Compugen Bapotulimab search interest

There is not enough data for Compugen Bapotulimab to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Compugen Bapotulimab to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Compugen Rilvegostomig to provide analysis

Correlation between past revenue and Compugen Rilvegostomig search interest

There is not enough data for Compugen Rilvegostomig to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Compugen Rilvegostomig to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Compugen clinical trials to provide analysis

Correlation between past revenue and Compugen clinical trials search interest

There is not enough data for Compugen clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Compugen clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Compugen jobs to provide analysis

Correlation between past revenue and Compugen jobs search interest

There is not enough data for Compugen jobs to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Compugen jobs to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Compugen stock price to provide analysis

Correlation between past revenue and Compugen stock price search interest

There is not enough data for Compugen stock price to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Compugen stock price to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 05 2023 18:33:19.

After 34 days of this quarter the interest is at 250.0. Based on that we can calculate that during remaining 58 days it will total up to 676.0.
Biotechnology industry expected interest is significantly higher compared to previous quarter (+97.7%) and same quarter last year (+72.4%).

YearQ1Q2Q3Q4
2018 - - - 155
2019 533
243.9% QoQ
500
-6.2% QoQ
317
-36.6% QoQ
377
143.2% YoY 18.9% QoQ
2020 496
-6.9% YoY 31.6% QoQ
352
-29.6% YoY -29.0% QoQ
418
31.9% YoY 18.8% QoQ
343
-9.0% YoY -17.9% QoQ
2021 443
-10.7% YoY 29.2% QoQ
460
30.7% YoY 3.8% QoQ
315
-24.6% YoY -31.5% QoQ
319
-7.0% YoY 1.3% QoQ
2022 554
25.1% YoY 73.7% QoQ
648
40.9% YoY 17.0% QoQ
407
29.2% YoY -37.2% QoQ
392
22.9% YoY -3.7% QoQ
2023 638
15.2% YoY 62.8% QoQ
478
-26.2% YoY -25.1% QoQ
342
-16.0% YoY -28.5% QoQ
250
-36.2% YoY -26.9% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Biotechnology industry search interestLast update: November 05 2023 18:33:19.
Correlation coefficient between keyword and revenue is 0.55
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 05 2023 18:33:19.

The average 5 years interest of Biotechnology industry was 33.6 per week.
The last year interest of Biotechnology industry compared to the last 5 years has changed by 11.1%.
The interest for Biotechnology industry is seasonal.
The last year interest is quite higher compared to 5 years ago. It has increased by 16.88%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for CGEN
Earnings date: 2024-02-22 After close
Company name: Compugen Ltd
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-12T07:00:00-04:00

PR Newswire
Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum

2026-05-04T07:00:00-04:00

PR Newswire
Compugen to Release First Quarter 2026 Results on Monday, May 18, 2026

2026-04-09T07:00:00-04:00

PR Newswire
Compugen to Participate in 25th Annual Needham Virtual Healthcare Conference

2026-04-07T12:40:42Z

Analyst Upgrades
Lake Street Initiates Coverage On Compugen with Buy Rating, Announces Price Target of $6

2026-03-02T07:00:00-05:00

PR Newswire
Compugen Reports Fourth Quarter and Full Year 2025 Results

2026-02-19T07:00:00-05:00

PR Newswire
Compugen to Participate in Upcoming Investor Conferences

2026-02-17T07:00:00-05:00

PR Newswire
Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026

2026-02-12T07:00:00-05:00

PR Newswire
Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors

2026-01-07T11:49:28Z

Analyst Upgrades
HC Wainwright & Co. Initiates Coverage On Compugen with Buy Rating, Announces Price Target of $4

2025-12-17T07:00:00-05:00

PR Newswire
Compugen Monetizes Portion of Rilvegostomig Future Royalties to AstraZeneca for Up to $90 Million

2025-11-10T07:00:00-05:00

PR Newswire
Compugen Reports Third Quarter 2025 Results

2025-11-04T07:00:00-05:00

PR Newswire
Compugen to Participate in Stifel 2025 Healthcare Conference

2025-10-27T07:00:00-04:00

PR Newswire
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025

2025-10-14T07:00:16-04:00

SEC
6-K Form - Report of foreign issuer [Rules 13a-16 and 15d-16] - COMPUGEN LTD (0001119774) (Filer)

2025-10-13T07:00:00-04:00

PR Newswire
Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025